Novo Nordisk (India)

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

Aaron S. Kelly, Pernille Auerbach, Margarita Barrientos‐Pérez et al. · New England Journal of Medicine · 2020 · 617 citations · Full text

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial

Bernard Zinman, Vaishali Bhosekar, Robert S. Busch et al. · The Lancet Diabetes & Endocrinology · 2019 · 336 citations

Diabetes Management, Sglt-2 Inhibitor Therapy, Medicine +7

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice

Bidda Rolin, Marianne O. Larsen, C. F. Gotfredsen et al. · American Journal of Physiology-Endocrinology and Metabolism · 2002 · 280 citations

Diabetic Mice, Food Intake, Insulin Signaling +19

European Study on Orthopaedic Status of haemophilia patients with inhibitors

Massimo Morfini, Saturnino Haya, Giuseppe Tagariello et al. · Haemophilia · 2007 · 215 citations

Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

T. Vilsbøll, Birgitte Brock, Hans Perrild et al. · Diabetic Medicine · 2008 · 210 citations